Institute of Public Health Albania
VALIDATE Members
VALIDATE Seminar: BCG & COVID - A century-old vaccine in a novel proposal for heterologous recall dose formulation
Paulo Antas and Thales A Campelo explored a potential boost in immune response with a second dose of BCG vaccine, prompting reconsideration of its use for TB prevention and exploring its effectiveness against COVID-19.
VALIDATE Seminar: Development of recombinant BCG Vaccine for tuberculosis utilizing Major Membrane Protein-II (MMP-II) antigen
Dr Tsukamoto discussed her work identifying an immunogenic Major Membrane Protein-II (MMP-II) antigen from Mycobacterium leprae, which led to the development of a new recombinant BCG vaccine.
VALIDATE Seminar: Leveraging synthetic carbohydrate chemistry to develop glycoconjugate vaccines against melioidosis
In this seminar, Charles and Maude will describe their endeavor toward the development of semi-synthetic glycoconjugate vaccines against melioidosis, focusing on our most promising results involving B. pseudomallei LPS OAg mimics.
